"Designing Growth Strategies is in our DNA"

U.S. Biosimilars Market Size, Share & COVID-19 Impact Analysis, By Drug Class (Filgrastim & Pegfilgrastim, Monoclonal Antibodies, and Others), By Disease Indication (Cancer, Autoimmune Diseases {Arthritis, Psoriasis, Neutropenia, and Others}, and Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and Regional Forecast, 2022-2029

Region : United States | Format: PDF | Report ID: FBI100990

 

Companies Who Rely On Us For Their Market Research Needs
3M
abbvie
Amgen
Ansell
Fresenius
Galemed
Grifols
Ipsos
iqvia
Johnson

Speak to Analyst

Refresh Button
U.S. Biosimilars Market Size, Share and Global Industry Trend Forecast till 2025
  • May, 2022
  • 2021
  • 2018-2020
  • 105

    CHOOSE LICENSE TYPE

  • $2850
    $3850
    $5850






We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies . Privacy.
X